solid tumor

cancer target detection radiopharma radio

Biotech

Big Pharmas back Strand's $153M series B to advance mRNA drugs

An impressive array of Big Pharma backers lined up to ensure Strand has the funds needed to advance its mRNA-based solid tumor drugs.

James Waldron Aug 7, 2025 9:20am

embryonic stem cells

Cell therapy biotech keeps adapting, selling 4 programs for $55M

Jul 28, 2025 10:52am

pivot change turnaround direction walk away

Roche axes Carmot obesity asset, 3 cancer drugs in R&D clear-out

Jul 24, 2025 5:00am

spray painting

BMS-backed Dispatch unveils with $216M, Carl June as cofounder

Jul 23, 2025 6:30am

I-Mab buys Bridge Health for $3M to strengthen givastomig push

Jul 17, 2025 8:45am

An arrow incrementally going up stairs before pointing straight up Blue background

Biokin, having landed BMS deal, posts ph. 3 bispecific ADC win

Jul 2, 2025 9:53am